Search Ontology:
ChEBI
pimavanserin
- Term ID
- CHEBI:133017
- Synonyms
-
- N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide
- N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea
- pimavanserin
- Definition
- A member of the class of ureas in which three of the four hydrogens are replaced by 4-fluorobenzyl, 1-methylpiperidin-4-yl, and 4-(isopropyloxy)benzyl groups. An atypical antipsychotic that is used (in the form of its tartrate salt) for treatment of hallucinations and delusions associated with Parkinson's disease.
- References
-
- CAS:706779-91-1
- Drug_Central:5142
- PMID:16469866
- PMID:19040345
- PMID:19864614
- PMID:19907417
- PMID:21256805
- PMID:21921840
- PMID:22750845
- PMID:22954754
- PMID:23969614
- PMID:24016069
- PMID:24183563
- PMID:24183566
- PMID:24247322
- PMID:24292660
- PMID:24682754
- PMID:25655720
- PMID:26744739
- PMID:26908168
- PMID:27242287
- PMID:27245248
- PMID:27249096
- PMID:27261226
- PMID:27262680
- PMID:27503570
- Patent:CA2652300
- Reaxys:10386699
- Wikipedia:Pimavanserin
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from pimavanserin
Phenotype where environments contain pimavanserin
Phenotype modified by environments containing pimavanserin
Human Disease Model